Clinical Trial Update: Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial assessing duration of action, safety and tolerability of UK369,003 in combination with Cialis for erectile dysfunction. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Cialis (tadalafil)
• UK369,003

Snippet

Sponsor: Pfizer | Conditions: Impotence | Phase 2 | Status: COMPLETED